B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Signaling by EGFR

REACTOME PATHWAY
Reactome: R-HSA-1779299 genes29 compounds

The Signaling by EGFR pathway (Reactome ID: R-HSA-177929) involves 9 genes and is affected by 29 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

ADAM10ADAM17CDC42CSKEGFRGRB2PIK3R1PTPRKSRC

Compounds Affecting Signaling by EGFR

#CompoundTargets HitStudies
1Dasatinib299
2tyrphostin ag 14784
3Sorafenib300
4Quercetin300
5Afatinib297
6Bisphenol A-Glycidyl Methacrylate197
7Kaempferols300
8Resveratrol298
9Adenosine Monophosphate Adenine nucleotide containing300
10alsterpaullone12
11Crizotinib298
12kenpaullone8
13monorden8
14Niclosamide299
15pictilisib25
16Wortmannin300
17ly29400211
18alpelisib227
19Sirolimus300
20torin 110
21ag49014
22tyrphostin 11
23Progesterone299
24Hexachlorophene300
25Prednisolone1,000
26Axitinib298
27casin10
28Dactinomycin297
29Sodium Fluoride299

About the Signaling by EGFR Pathway

The Signaling by EGFR pathway is catalogued in Reactome (ID: R-HSA-177929) and involves 9 genes. In the BiohacksAI corpus, 29 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ADAM10, ADAM17, CDC42, CSK, EGFR.